BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Terumo BCT Showcases 3-in-1 CAR-T Manufacturing Protocol in Cytotherapy

Protocol published in Cytotherapy1 shows activation and viral transduction can be performed on Terumo BCT’s Quantum Cell Expansion System.&nbs...

June 19, 2025 | News

RemeGen’s Telitacicept Secures EMA Orphan Drug Designation for Myasthenia Gravis, Advancing Global Development

RemeGen Co., Ltd. ("RemeGen", stock symbols: 688331.SH/09995.HK) announced that telitacicept (RC18; brand name: 泰爱®) has received Orphan Drug Desig...

June 18, 2025 | News

Pierre Fabre Acquires Global Rights to Next-Generation EGFR Inhibitors for Lung Cancer

Pierre Fabre Laboratories are pleased to announce the acquisition from Antares Therapeutics, Inc. ("Antares"), a spin-out of Scorpion Therapeutics, Inc., o...

June 17, 2025 | News

BioDlink Secures NAFDAC Approval for Bevacizumab Injection, Marking Strategic Entry into the African Market

BioDlink's Bevacizumab Injection has been granted marketing authorization by Nigeria's National Agency for Food and Drug Administration an...

June 17, 2025 | News

Teva and Fosun Pharma Enter Strategic Partnership to Advance Anti-PD1-IL2 ATTENUKINE™ Therapy TEV-56278 for Oncology

Teva-engineered TEV-56278 is an anti-PD1-IL2 ATTENUKINE™ therapy in Phase 1 for the treatment of various forms of cancer, including melanoma Fosun...

June 17, 2025 | News

HELP Therapeutics and China Resources Sanjiu Forge Strategic Partnership to Advance Groundbreaking iPSC-Derived Therapy for Heart Failure in China

HELP Therapeutics, a global leader in regenerative medicine, and China Resources Sanjiu Pharmaceutical Company, one of China's largest pharmaceut...

June 17, 2025 | News

Abbisko Begins Registrational Trial of Irpagratinib, a Precision FGFR4 Inhibitor, for Advanced Liver Cancer

Abbisko Therapeutics announced that it has completed first patient dosing in a registrational study of irpagratinib, a self-developed and highly-selective ...

June 17, 2025 | News

Debiopharm and Alkyon Therapeutics Join Forces to Advance Precision Radioligand Cancer Therapies

Research program combining Debiopharm’s AbYlink™ conjugation technology with Alkyon’s modular antibody platform and novel targeting app...

June 16, 2025 | News

Aragen to Launch GMP Biologics Manufacturing in India by July 2025

Aragen, a leading contract research, development and manufacturing organization (CRDMO), announced that it will commence GMP manufacturing at its biol...

June 16, 2025 | News

Visterra Licenses Nona Biosciences’ HCAb Harbour Mice® Platform to Advance Autoimmune Biotherapeutics

Nona Biosciences, a global biotechnology company providing integrated solutions from "Idea to IND" (I to ITM), today announced a license agreeme...

June 13, 2025 | News

Hoth Therapeutics Secures Japan Patent for HT-KIT Splice-Switching Platform Targeting Mast Cell Disorders

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company developing innovative therapies, today announced that they have obtained...

June 13, 2025 | News

Specialised Therapeutics Expands Incyte Partnership to Launch Axatilimab and Retifanlimab in Asia-Pacific

Independent biopharmaceutical company Specialised Therapeutics (ST) is pleased to announce the expansion of its existing supply and distribution agree...

June 13, 2025 | News

Thermo Fisher’s Olink Explore HT Selected by Regeneron Genetics Center for 200,000-Sample Proteomics Study

Thermo Fisher Scientific, the world leader in serving science, today announced that the Regeneron Genetics Center® (RGC™) has selected the O...

June 13, 2025 | News

Shilpa Biocare Inks Europe-Wide Supply Deal with Orion for Recombinant Human Albumin

Shilpa Biocare Private Limited, a fully-owned subsidiary of Shilpa Medicare Limited (“Shilpa”), announces ahead of BIO Boston that it...

June 13, 2025 | News

Stay Connected